L&C Bio Co., Ltd (290650.KQ)

KRW 20700.0

(0.49%)

Operating Expenses Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual operating expenses in 2023 was 25.86 Billion KRW , up 47.71% from previous year.
L&C Bio Co., Ltd's latest quarterly operating expenses in 2024 Q2 was 7.58 Billion KRW , up 21.19% from previous quarter.
L&C Bio Co., Ltd reported a annual operating expenses of 17.5 Billion KRW in annual operating expenses 2022, up 14.58% from previous year.
L&C Bio Co., Ltd reported a annual operating expenses of 15.28 Billion KRW in annual operating expenses 2021, up 24.9% from previous year.
L&C Bio Co., Ltd reported a quarterly operating expenses of 7.58 Billion KRW for 2024 Q2, up 21.19% from previous quarter.
L&C Bio Co., Ltd reported a quarterly operating expenses of 5.39 Billion KRW for 2023 Q1, up 23.58% from previous quarter.

Annual Operating Expenses Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Operating Expenses of L&C Bio Co., Ltd (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	25.86 Billion KRW	47.71%
2022	17.5 Billion KRW	14.58%
2021	15.28 Billion KRW	24.9%
2020	12.23 Billion KRW	27.02%
2019	9.63 Billion KRW	21.86%
2018	7.9 Billion KRW	26.17%
2017	6.26 Billion KRW	27.43%
2016	4.91 Billion KRW	54.36%
2015	3.18 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	6 Billion KRW	-22.39%
2024 Q2	7.58 Billion KRW	21.19%
2023 Q1	5.39 Billion KRW	23.58%
2023 Q4	7.73 Billion KRW	10.02%
2023 FY	25.86 Billion KRW	47.71%
2023 Q2	6.46 Billion KRW	19.66%
2023 Q3	7.03 Billion KRW	8.83%
2022 Q2	4.3 Billion KRW	-3.08%
2022 FY	17.5 Billion KRW	14.58%
2022 Q4	4.36 Billion KRW	-0.53%
2022 Q3	4.39 Billion KRW	2.05%
2022 Q1	4.44 Billion KRW	4.07%
2021 Q2	2.79 Billion KRW	-32.35%
2021 Q3	4.08 Billion KRW	46.27%
2021 Q4	4.26 Billion KRW	4.41%
2021 FY	15.28 Billion KRW	24.9%
2021 Q1	4.13 Billion KRW	-3.27%
2020 Q3	2.54 Billion KRW	-10.67%
2020 Q4	4.27 Billion KRW	67.63%
2020 FY	12.23 Billion KRW	27.02%
2020 Q1	2.56 Billion KRW	5.79%
2020 Q2	2.85 Billion KRW	11.22%
2019 Q4	2.42 Billion KRW	2.25%
2019 FY	9.63 Billion KRW	21.86%
2019 Q3	2.37 Billion KRW	-6.8%
2019 Q2	2.54 Billion KRW	10.87%
2019 Q1	2.29 Billion KRW	-7.14%
2018 Q2	1.99 Billion KRW	20.49%
2018 Q1	1.65 Billion KRW	0.0%
2018 Q3	1.78 Billion KRW	-10.67%
2018 Q4	2.47 Billion KRW	38.62%
2018 FY	7.9 Billion KRW	26.17%
2017 FY	6.26 Billion KRW	27.43%
2016 FY	4.91 Billion KRW	54.36%
2015 FY	3.18 Billion KRW	0.0%

Peer Operating Expenses Comparison of L&C Bio Co., Ltd

Name	Operating Expenses	Operating Expenses Difference
Osang Healthcare Co.,Ltd	78.35 Billion KRW	66.997%
InBody Co.,Ltd	87.36 Billion KRW	70.399%
Curexo Inc.	18.16 Billion KRW	-42.381%
Seegene, Inc.	210.08 Billion KRW	87.69%
i-SENS, Inc.	91.12 Billion KRW	71.622%
Ray Co., Ltd.	59.03 Billion KRW	56.192%
Gencurix Inc.	12.79 Billion KRW	-102.067%
Sugentech Inc.	18.6 Billion KRW	-39.01%